Abstract
The European Parliament has passed draft regulations aimed at making tobacco products less appealing to young people. Should e-cigarettes be regulated as a medicinal device?There are more than 1 billion smokers worldwide. About half of individuals who continue smoking will die prematurely because of toxins in tobacco smoke. Over the past few years, smokers in economically developed countries have been showing growing interest in electronic cigarettes (ECs) that are designed to deliver nicotine without these toxins. Full-Text PDF Regulatory challenges for refined nicotine productsHistorically, refined nicotine has been sold in only two forms: a pesticide or a pharmaceutical grade medicinal product for tobacco addiction. Until recently, the US Food and Drug Administration (FDA) has consistently blocked the marketing of any non-pharmaceutical nicotine product designed for human consumption. The main exceptions to the rule are the electronic nicotine delivery systems (ENDS or electronic cigarettes): battery-powered devices that deliver refined nicotine in a humectant, usually propylene glycol. Full-Text PDF Regulation of e-cigarettes: the users' perspectiveWe read with great interest the Comments1,2 in The Lancet Respiratory Medicine, which debated if, how, and by whom electronic cigarettes (e-cigarettes) should be regulated. Full-Text PDF
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
